兽医感染疾病诊断市场－全球产业规模、份额、趋势、机会及预测（按技术、动物种类、最终用户、地区和竞争格局划分，2021-2031年）

全球兽医感染疾病诊断市场预计将从 2025 年的 16.1 亿美元成长到 2031 年的 21.9 亿美元，复合年增长率为 5.26%。

该领域涵盖各种实验室设备、试剂和免疫诊断试剂盒，这些对于检测家畜和伴侣动物体内的细菌、病毒和寄生虫病原体至关重要。推动这一增长的关键因素包括跨境通用感染疾病的日益流行，以及透过有效的动物健康管理来确保全球粮食安全的经济需求。此外，宠物人性化的趋势促使饲主更愿意投资先进的医疗保健，从而刺激了对快速、准确病原体检测的需求。世界动物卫生组织（OIE）的数据也印证了这项需求的迫切性：2024年1月至2025年5月期间，该组织记录了14,918例非洲猪瘟病例和6,346例高致病性禽流感病例。

儘管成长要素强劲，但由于先进分子诊断技术实施和营运成本高昂，市场仍面临许多障碍。这些资金限制往往阻碍了发展中地区采用先进的检测方法，因为这些地区的兽医预算有限，农业部门对价格仍然十分敏感。因此，这种经济障碍阻碍了许多感染疾病疫源地广泛采用尖端诊断技术，对全球市场的均衡扩张构成重大阻碍。

市场驱动因素

跨境动物疫病和通用感染疾病的日益蔓延是市场扩张的主要驱动力，这要求各国政府和农业机构优先实施严格的监测系统，以确保粮食安全。对生物安全的重视加速了先进诊断剂和设备的采购，这些试剂和设备能够快速识别牲畜体内的病原体。为了因应这些脆弱性，大量资金正投入加强检测基础设施建设。例如，2024年5月，美国农业部宣布通过《农业法案》拨款超过2,220万美元，用于81个旨在加强对威胁性动物疫病早期检测和快速反应能力的计划。这笔资金将直接用于支持诊断技术的应用，以减少经济损失。

同时，宠物饲养量的增加和宠物人性化的趋势正在从根本上改变兽医服务的结构，导致诊断和预防保健方面的支出不断增长。随着饲主越来越将宠物视为家庭成员，他们更愿意为先进的医学检测付费，这促使诊所扩大其内部检测能力。美国宠物用品协会 (APPA) 2024 年 8 月的报告也反映了这一趋势，该报告预测，到 2024 年，美国兽医保健及相关产品的总支出将达到 398 亿美元。产业领导者也支持这项需求，IDEXX Laboratories 在 2025 年公布的 2024 年全年销售额为 38.98 亿美元。这凸显了诊断产业的盈利，而这正是由上述两大市场力量所驱动的。

市场挑战

市场扩张的一大障碍是实施和营运先进分子诊断技术的高成本。这些精准检测平台需要大量的资金投入，并且依赖昂贵的试剂，这对于预算有限的畜牧养殖户和兽医诊所来说构成了很高的进入门槛。在对价格敏感的农业部门和发展中地区，这种经济负担往往迫使医疗专业人员依赖准确性较低的传统方法，而不是采用现代诊断方案，从而限制了市场在感染疾病高风险地区的潜在扩张。

兽医护理成本的整体上涨加剧了这一经济负担，限制了可用于高品质诊断服务的可支配收入。根据美国动物医院协会 (AAHA) 统计，2025 年犬隻的终身医疗费用较 2022 年增加了 11.65%。不断上涨的成本迫使农场主和宠物饲主仔细审查支出，越来越避免高成本的诊断程序，而选择基本的症状治疗。因此，这种经济限制直接阻碍了收入成长和先进诊断工具在全球的普及。

市场趋势

将人工智慧 (AI) 和机器学习融入诊断领域的趋势正在从根本上改变兽医学的实践，它能够自动化复杂的分析任务并提高诊断准确性。这一趋势透过将深度学习演算法整合到分析仪中，解决了专家短缺的问题，使临床医生能够即时获得细胞学和血液学检测的参考级解读结果。这项技术飞跃在近期的发展中得到了充分体现。 2024 年 12 月，硕腾公司 (Zoetis Inc.) 宣布对其 Vetscan Imagyst 平台进行人工智慧驱动的更新，透过引入可在数分钟内识别和区分白血球的新演算法，简化了诊断工作流程。

同时，就地检验(POC) 和快速诊断检测 (RDT) 的引入，已将感染疾病控制从中心检查室转移到医疗点，从而能够即时检测病原体。兽医可以利用现场分析仪快速实施生物安全措施和治疗方案，为控制传染病爆发提供了关键能力。市场向这些解决方案的转变在财务表现中显而易见。 2024 年 10 月，IDEXX Laboratories, Inc. 报告称，其全球高端设备安装量年增 10%，证实了诊所对快速院内诊断基础设施的投资不断增加。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球兽医感染疾病诊断市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依技术分类（免疫诊断、分子诊断、其他兽医诊断技术）
  • 动物类型（伴侣动物、肉类动物）
  • 依最终使用者（参考实验室、兽医实验室/诊所、照护现场/院内检测、研究机构/大学）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美兽医感染疾病诊断市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲兽医感染疾病诊断市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区兽医感染疾病诊断市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲兽医感染疾病诊断市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲兽医感染疾病诊断市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球兽医感染疾病诊断市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• BIOMeRIEUX
• Heska Corporation
• Neogen Corporation
• INDICAL BIOSCIENCE GmbH
• Randox Laboratories Ltd.
• Thermo Fisher Scientific Inc.
• Creative Diagnostics
• DRG INSTRUMENTS GMBH
• Chembio Diagnostic Systems, Inc.
• Eurofins Technologies
• Agrolabo SpA
• Abbott Laboratories inc.
• Danaher Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Veterinary Infectious Disease Diagnostics Market is projected to expand from USD 1.61 Billion in 2025 to USD 2.19 Billion by 2031, reflecting a compound annual growth rate of 5.26%. This sector encompasses a variety of laboratory instruments, reagents, and immunodiagnostic kits essential for detecting bacterial, viral, and parasitic pathogens in livestock and companion animals. Key drivers propelling this growth include the rising prevalence of transboundary zoonotic diseases and the economic imperative to ensure global food security through effective herd health management. Additionally, the trend of pet humanization has increased owner willingness to fund advanced healthcare, thereby stimulating demand for rapid and precise pathogen detection. The urgency of this demand is highlighted by World Organisation for Animal Health data, which recorded 14,918 outbreaks of African swine fever and 6,346 outbreaks of high pathogenicity avian influenza between January 2024 and May 2025.

Despite these strong growth drivers, the market encounters significant obstacles due to the high acquisition and operational costs associated with advanced molecular diagnostic technologies. These financial constraints frequently limit the adoption of precise testing methods in developing regions where veterinary budgets are restricted and agricultural sectors remain price-sensitive. Consequently, this economic barrier hampers the widespread deployment of state-of-the-art diagnostics in areas where many infectious outbreaks originate, creating a substantial impediment to the uniform expansion of the global market.

Market Driver

The escalating prevalence of transboundary and zoonotic animal diseases serves as a primary engine for market expansion, necessitating that governments and agricultural bodies prioritize rigorous surveillance systems to ensure food security. This focus on biosecurity accelerates the procurement of advanced diagnostic reagents and instruments capable of rapid pathogen identification in livestock. To address these vulnerabilities, significant financial resources are being allocated to strengthen detection infrastructure. For instance, the U.S. Department of Agriculture announced in May 2024 that it awarded over $22.2 million in Farm Bill funding to 81 projects aimed at enhancing early detection and rapid response capabilities for threatening animal diseases, directly subsidizing the adoption of diagnostic technologies to mitigate economic losses.

Simultaneously, the rising adoption of companion animals and the phenomenon of pet humanization are fundamentally altering the veterinary services landscape, leading to increased expenditure on diagnostic and preventative healthcare. As owners increasingly view pets as family members, their willingness to pay for sophisticated medical testing has grown, incentivizing clinics to upgrade their on-site testing capabilities. This trend is reflected in the American Pet Products Association's August 2024 report, which noted that total U.S. spending on veterinary care and products reached $39.8 billion in 2024. Leading industry players further evidence this demand; IDEXX Laboratories reported full-year 2024 revenues of $3.898 billion in 2025, underscoring the lucrative nature of the diagnostics sector driven by these dual market forces.

Market Challenge

The primary obstacle to market expansion is the prohibitive cost associated with acquiring and operating advanced molecular diagnostic technologies. These sophisticated testing platforms require substantial capital investment and rely on expensive reagents, creating a high barrier to entry for livestock producers and veterinary clinics with limited budgets. In price-sensitive agricultural sectors and developing regions, these financial demands often force practitioners to rely on traditional, less accurate methods rather than adopting modern diagnostic solutions, thereby stifling the market's potential reach in areas where infectious risks are frequently highest.

This economic strain is exacerbated by the broader escalating costs of animal healthcare, which limit the disposable income available for premium diagnostic services. According to the American Animal Hospital Association, the lifetime cost of care for a dog increased by 11.65% in 2025 compared to 2022 levels. Such rising expenses compel farmers and pet owners to scrutinize spending, often resulting in the rejection of high-cost diagnostic procedures in favor of basic symptomatic treatments. Consequently, this financial reticence directly hampers revenue growth and the widespread global adoption of advanced diagnostic tools.

Market Trends

The integration of Artificial Intelligence and Machine Learning into diagnostics is fundamentally reshaping veterinary practice by automating complex analytical tasks and improving diagnostic accuracy. This trend addresses the shortage of specialists by embedding deep learning algorithms into analyzers, allowing practitioners to obtain reference-quality interpretations for cytology and hematology in real-time. This technological leap is evidenced by recent advancements; in December 2024, Zoetis Inc. announced AI-driven updates to its Vetscan Imagyst platform, including a new algorithm capable of identifying and differentiating white blood cells within minutes, thereby streamlining the diagnostic workflow.

Concurrently, the adoption of Point-of-Care and Rapid Diagnostic Testing is shifting infectious disease management from central laboratories to the clinic, facilitating immediate pathogen detection. By utilizing on-site analyzers, veterinarians can rapidly implement biosecurity measures and treatment plans, a capability essential for controlling contagious outbreaks. The market's pivot toward these solutions is quantified by financial performance; IDEXX Laboratories, Inc. reported in October 2024 a 10% year-over-year growth in its global premium instrument installed base, underscoring the increasing investment by practices in rapid, in-house diagnostic infrastructure.

Key Market Players

• BIOMeRIEUX
• Heska Corporation
• Neogen Corporation
• INDICAL BIOSCIENCE GmbH
• Randox Laboratories Ltd.
• Thermo Fisher Scientific Inc.
• Creative Diagnostics
• DRG INSTRUMENTS GMBH
• Chembio Diagnostic Systems, Inc.
• Eurofins Technologies
• Agrolabo S.p.A.
• Abbott Laboratories inc.
• Danaher Corporation

Report Scope

In this report, the Global Veterinary Infectious Disease Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Infectious Disease Diagnostics Market, By Technology

• Immunodiagnostics
• Molecular Diagnostics
• Other Veterinary Diagnostic Technologies

Veterinary Infectious Disease Diagnostics Market, By Animal Type

• Companion Animals
• Food Producing Animals

Veterinary Infectious Disease Diagnostics Market, By End User

• Reference Laboratories
• Veterinary Laboratories and Clinics
• Point of Care / In House Testing
• Research Institutes and Universities

Veterinary Infectious Disease Diagnostics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Infectious Disease Diagnostics Market.

Available Customizations:

Global Veterinary Infectious Disease Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Infectious Disease Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Immunodiagnostics, Molecular Diagnostics, Other Veterinary Diagnostic Technologies)
  • 5.2.2. By Animal Type (Companion Animals, Food Producing Animals)
  • 5.2.3. By End User (Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care / In House Testing, Research Institutes and Universities)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Veterinary Infectious Disease Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Animal Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Veterinary Infectious Disease Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Animal Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Veterinary Infectious Disease Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Animal Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Veterinary Infectious Disease Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Animal Type
      • 6.3.3.2.3. By End User

7. Europe Veterinary Infectious Disease Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Animal Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Veterinary Infectious Disease Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Animal Type
      • 7.3.1.2.3. By End User
  • 7.3.2. France Veterinary Infectious Disease Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Animal Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Veterinary Infectious Disease Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Animal Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Veterinary Infectious Disease Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Animal Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Veterinary Infectious Disease Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Animal Type
      • 7.3.5.2.3. By End User

8. Asia Pacific Veterinary Infectious Disease Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Animal Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Veterinary Infectious Disease Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Animal Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Veterinary Infectious Disease Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Animal Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Veterinary Infectious Disease Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Animal Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Veterinary Infectious Disease Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Animal Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Veterinary Infectious Disease Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Animal Type
      • 8.3.5.2.3. By End User

9. Middle East & Africa Veterinary Infectious Disease Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Animal Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Veterinary Infectious Disease Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Animal Type
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Veterinary Infectious Disease Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Animal Type
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Veterinary Infectious Disease Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Animal Type
      • 9.3.3.2.3. By End User

10. South America Veterinary Infectious Disease Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Animal Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Veterinary Infectious Disease Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Animal Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Veterinary Infectious Disease Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Animal Type
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Veterinary Infectious Disease Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Animal Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Veterinary Infectious Disease Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. BIOMeRIEUX
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Heska Corporation
• 15.3. Neogen Corporation
• 15.4. INDICAL BIOSCIENCE GmbH
• 15.5. Randox Laboratories Ltd.
• 15.6. Thermo Fisher Scientific Inc.
• 15.7. Creative Diagnostics
• 15.8. DRG INSTRUMENTS GMBH
• 15.9. Chembio Diagnostic Systems, Inc.
• 15.10. Eurofins Technologies
• 15.11. Agrolabo S.p.A.
• 15.12. Abbott Laboratories inc.
• 15.13. Danaher Corporation

16. Strategic Recommendations

17. About Us & Disclaimer